GE HealthCare Technologies Inc. (BIT:1GEHC)
Italy
· Delayed Price · Currency is EUR 70.46
+1.11 (1.60%)
At close: Dec 3, 2025
Revenue Breakdown
Fiscal year is January - December.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 |
|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 |
| Product Revenue | 13.38B | 13.08B |
Log In |
Log In |
Log In | Upgrade
|
| Service Revenue | 6.87B | 6.60B |
Log In |
Log In |
Log In | Upgrade
|
| Revenue (Other) | -1.00M | - |
Log In |
Log In |
Log In | Upgrade
|
| Revenue (Total) | 20.25B | 19.67B |
Log In |
Log In |
Log In | Upgrade
|
Revenue Breakdown 2
Fiscal year is January - December.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 |
|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 |
| Imaging Revenue (Post-Q2 2024) | 9.09B | 8.86B |
Log In |
Log In |
Log In | Upgrade
|
| Advanced Visualization Solutions (AVS) Revenue | 5.27B | 5.13B |
Log In |
Log In |
Log In | Upgrade
|
| Patient Care Solutions (PCS) Revenue | 3.09B | 3.13B |
Log In |
Log In |
Log In | Upgrade
|
| Pharmaceutical Diagnostics (PDx) Revenue | 2.76B | 2.51B |
Log In |
Log In |
Log In | Upgrade
|
| Other Revenue | 47.00M | 52.00M |
Log In |
Log In |
Log In | Upgrade
|
| Revenue (Total) | 20.25B | 19.67B |
Log In |
Log In |
Log In | Upgrade
|
Revenue Breakdown 3
Fiscal year is January - December.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 |
|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 |
| Patient Care Solutions (PCS) Revenue | 3.09B | 3.13B |
Log In |
Log In |
Log In | Upgrade
|
| Pharmaceutical Diagnostics (PDx) Revenue | 2.76B | 2.51B |
Log In |
Log In |
Log In | Upgrade
|
| Other Revenue | 47.00M | 52.00M |
Log In |
Log In |
Log In | Upgrade
|
| Imaging Revenue | - | - |
Log In |
Log In |
Log In | Upgrade
|
| Ultrasound Revenue | - | - |
Log In |
Log In |
Log In | Upgrade
|
| Revenue (Total) | 20.25B | 19.67B |
Log In |
Log In |
Log In | Upgrade
|
Revenue by Geography
Fiscal year is January - December.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 |
|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 |
| USCAN Revenue | 9.33B | 8.98B |
Log In |
Log In |
Log In | Upgrade
|
| EMEA Revenue | 5.24B | 5.05B |
Log In |
Log In |
Log In | Upgrade
|
| China Revenue | 2.32B | 2.36B |
Log In |
Log In |
Log In | Upgrade
|
| Rest of World Revenue | 3.36B | 3.28B |
Log In |
Log In |
Log In | Upgrade
|
| Revenue (Other) | -3.00M | - |
Log In |
Log In |
Log In | Upgrade
|
| Revenue (Total) | 20.25B | 19.67B |
Log In |
Log In |
Log In | Upgrade
|
EBIT
Fiscal year is January - December.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 |
|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 |
| Imaging EBIT (Post-Q2 2024) | 929.00M | 962.00M |
Log In |
Log In |
Log In | Upgrade
|
| Advanced Visualization Solutions (AVS) EBIT | 1.17B | 1.12B |
Log In |
Log In |
Log In | Upgrade
|
| Patient Care Solutions (PCS) Segment EBIT | 241.00M | 347.00M |
Log In |
Log In |
Log In | Upgrade
|
| Pharmaceutical Diagnostics (PDx) Segment EBIT | 850.00M | 783.00M |
Log In |
Log In |
Log In | Upgrade
|
| Other Segment EBIT | 6.00M | 2.00M |
Log In |
Log In |
Log In | Upgrade
|
| Operating Income (Other) | -462.00M | -587.00M |
Log In |
Log In |
Log In | Upgrade
|
| Operating Income (Total) | 2.74B | 2.63B |
Log In |
Log In |
Log In | Upgrade
|
EBIT 2
Fiscal year is January - December.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 |
|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 |
| Patient Care Solutions (PCS) Segment EBIT | 241.00M | 347.00M |
Log In |
Log In |
Log In | Upgrade
|
| Pharmaceutical Diagnostics (PDx) Segment EBIT | 850.00M | 783.00M |
Log In |
Log In |
Log In | Upgrade
|
| Other Segment EBIT | 6.00M | 2.00M |
Log In |
Log In |
Log In | Upgrade
|
| Imaging Segment EBIT | - | - |
Log In |
Log In |
Log In | Upgrade
|
| Ultrasound Segment EBIT | - | - |
Log In |
Log In |
Log In | Upgrade
|
| Operating Income (Total) | 2.74B | 2.63B |
Log In |
Log In |
Log In | Upgrade
|
Key Performance Indicators
Fiscal year is January - December.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 |
|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 |
| Products Remaining Performance Obligations (RPO) | 4.90B | 4.76B |
Log In |
Log In |
Log In | Upgrade
|
| Services Remaining Performance Obligations (RPO) | 10.20B | 9.74B |
Log In |
Log In |
Log In | Upgrade
|
| Total Remaining Performance Obligations (RPO) | 15.10B | 14.49B |
Log In |
Log In |
Log In | Upgrade
|